3/15/2012

AdvaMed has tapped Zimmer President and CEO David Dvorak to succeed Jim Mazzo as the group's board chairman. During his two-year term as chairman, Dvorak aims to focus on issues such as repealing the 2.3% medical device tax and implementing the revised user fee agreement with the FDA, according to a release.

Related Summaries